News and Announcements
SUDA Investor Presentation May 2016
- Published May 03, 2016 4:42PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd May 2016, ASX Announcement
Overview
SUDA (ASX: SUD) is a drug delivery company commercialising low-risk pharmaceuticals
Extensive proprietary technology, expertise and knowhow in formulating and manufacturing oral sprays
Multiple patent families covering approx. 300 widely-used drugs formulated into oral sprays
SUDA’s first-in-class oral sprays have demonstrated meaningful advantages vs. standard-of-care tablets in multiple clinical studies
Multiple oral sprays for large markets – insomnia, malaria, migraine, erectile dysfunction, chemo-induced nausea
Technology proven with 3 products on the market: NitroMist (Nitro-Glycerine), ZolpiMist and Meloxicam (Vet)
To view the presentation please click on the button below.